Loading...
We would love for you to become a part of our community. Join our Discord to connect with us and other members!
- Ticker
- SCU.AU
- Price
- -
- Stock movement up
- +- (%)
- Company name
- Stemcell United Ltd
- Exchange
- (AU ,
- Currency
- AUD )
- Sector
- Healthcare >Drug Manufacturers-Specialty & Generic
- Market cap
- 2.57M
- Ent value
- -
- Price/Sales
- 0.18
- Price/Book
- 3.24
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -21.64%
- 1 year return
- -85.82%
- 3 year return
- -54.55%
- 5 year return
- -27.81%
- 10 year return
- -
Last updated: 2024-12-17
DIVIDENDS
SCU.AU does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 0.18 |
| Price to Book | 3.24 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 1.28B |
| EPS (TTM) | -0.01 |
| FCF per share (TTM) | -0.00 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 14.34M |
| Gross profit (TTM) | -300.62K |
| Operating income (TTM) | -5.08M |
| Net income (TTM) | -6.61M |
| EPS (TTM) | -0.01 |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | -2.10% |
| Operating margin (TTM) | -35.40% |
| Profit margin (TTM) | -46.09% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 0.00 |
| Net receivables | 55.99K |
| Total current assets | 1.29M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 2.00M |
| Accounts payable | 0.00 |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 1.03M |
| Total liabilities | 1.21M |
| Shareholder's equity | 793.13K |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -3.51M |
| Capital expenditures (TTM) | 659.29K |
| Free cash flow (TTM) | -4.17M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -833.29% |
| Return on Assets | -329.87% |
| Return on Invested Capital | -833.29% |
| Cash Return on Invested Capital | -526.26% |
STOCK INFORMATION
Downside potential
Loading...
Downside potential data
| SCU.AU | S&P500 | |
| Current price drop from All-time high | -99.32% | -6.66% |
| Highest price drop | -99.32% | -56.47% |
| Date of highest drop | 10 Aug 2023 | 9 Mar 2009 |
| Avg drop from high | -69.97% | -11.13% |
| Avg time to new high | 89 days | 12 days |
| Max time to new high | 1115 days | 1805 days |
COMPANY DETAILS
Marketcap
2.57M
Marketcap category
Small-cap
Description
Stemcell United Limited, together with its subsidiaries, engages in sourcing, producing, marketing, and selling traditional medicines in Australia, Singapore, Greater China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company was formerly known as On Q Group Limited and changed its name to Stemcell United Limited in September 2015. Stemcell United Limited was incorporated in 1984 and is headquartered in Sydney, Australia.
Employees
0
Website
Investor relations
-
SEC filings
CEO
Country
Australia
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found